Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

inical trial activities, the timing of completing certain operational initiatives, our ability to effect reductions in certain aspects of our budgets in an efficient and timely manner, and changes in interest rates. These and other uncertainties may adversely affect our liquidity and capital resources to a significant extent and may force us to further reduce our expenditures on research and development or on our various new product and sales and marketing initiatives in order for us to continue to service our debt obligations. Such further reductions in our budgeted expenditures may have an adverse effect on our new product development and sales growth initiatives and reduce our ability to achieve the revenue growth targets, product launch or new product development timelines in our current operating plan. There can also be no assurance that such reductions in expenditures will be adequate to provide enough cash flow to continue to service our current level of debt obligations.

In particular, should our royalties received from BSC decline more significantly than we expect in future periods as a result of new competitive entrants into the U.S. drug-eluting stent market, our liquidity may be adversely affected, and we may be forced to explore alternative funding sources through debt, equity or other public or private securities offerings, or to pursue certain reorganization, restructuring or other strategic alternatives. There can be no assurance that if we pursue such financing activities that alternative sources of funding would be available to us on attractive terms, if at all. In addition, we may not be able to complete any restructuring, reorganization or strategic activities on terms that would be favorable for us or our shareholders. Capital markets conditions have deteriorated significantly during 2008 and 2009, including a significant and material decline in the level of corporate lending activity, combined with a significant increase in the cost of
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... BARBARA, Calif. , March 2, 2015 /PRNewswire/ ... biotechnology company developing therapies for autoimmune and infectious ... Office (USPTO) has issued an important new composition ... system function through the targeting of CLIP. ... targeted peptide technology underlying VG Life Sciences, VG1177, ...
(Date:3/2/2015)... Outside GC, the leading provider of on-demand, in-house ... Casey as a member of the firm, further strengthening ... , Debbie has spent over 20 years in the ... North America in both legal and business capacities. ... Outside GC’s growing list of healthcare clients, with a ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine Inc. ... aware of a fraudulent press release disseminated this morning ... be from Immunovaccine. This press release states that Immunovaccine ... Inc. The press release did not originate from ... contained within the press release. Please note that ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
Breaking Biology Technology:VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Outside GC Expands Healthcare Team 2Immunovaccine Disclaims Hoax Press Release 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4
... MENLO PARK, Calif., June 3 Kornberg Associates | ... to design the research areas of the new Malaysia ... announcement. , , The Malaysia Genome ... research organization launched by the Malaysian government in April ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced ... InterMune, will present at the Goldman Sachs 30th Annual Global ... 2:35 p.m. ET. , , To access ... interested parties may log on to the investor relations page ...
... the House Nancy Pelosi (D-CA) apparently couldn,t resist injecting divisive ... of President Ronald Reagan today on Capital Hill. And ... misleading people again, this time with her statements on stem ... http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , , In discussing Nancy ...
Cached Biology Technology:Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute 2
(Date:3/2/2015)... March 2, 2015   Neurotechnology , a provider ... the SentiGaze Software Development Kit (SDK). The ... that use off-the-shelf webcams to track eye movements and ... a monitor. Heatmaps can be used for applications such ... online advertising. The SDK can also be used to ...
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Middle East , ... forecasts are provided for the period 2013 through 2020. Also, ... data and analytics are derived from primary and secondary research. ...
(Date:2/24/2015)... Feb. 24, 2015 Research and Markets ... of the "Global 2D Gesture Recognition Market ... The analysts forecast the Global 2D Gesture ... 32.12% over the period 2014-2019 The ... sectors is one of the major trends in ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2
... are hospitalized each year due to hyperemesis gravidarum (HG), an ... and often forces them to reluctantly terminate their pregnancies. ... grandmothers on either side of the family who have experienced ... be heightened, according to a new study led by researchers ...
... children reported more frequent intake of healthy foods such ... well as low-energy cheese and yoghurt compared with normal ... researchers at Telemark University College, Norway and the ... showed that: Overweight children drank ...
... of reef fish will enact punishment on the parasitic ... take a bite, even though their behavior offers no ... in Current Biology , a Cell Press publication, ... reef fish species well. In future attacks, blennies ...
Cached Biology News:Study shows extreme form of pregnancy-related morning sickness could be genetic 2Overweight children have different eating patterns than normal weight children 2To punish or not to punish: Lessons from reef fish and saber-tooth blennies 2To punish or not to punish: Lessons from reef fish and saber-tooth blennies 3
... Staining tray 19 x 29 cm, 1. ... blot processing.Automated staining of Coomassie Blue or ... analysis. Prepares blots for high sensitivity ECL ... protocol, solution, volume, and processing time.Proven design ...
Cytidine 5'-Triphosphate, Sodium (CTP), 1 g. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
... Blotting Reagent Pack, 1. Contains reagents ... membrane-bound mouse and rabbit primary antibodies. Designed ... Detection reagents are not included, but the ... Plus. Category: Blotting & Labeling & ...
... LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Diffuse We've ... Variable Filters to create the world's first ... and adjustable bandpass. Each filter features an ... (99.8%). These filters -- with interference ...
Biology Products: